Literature DB >> 2323062

Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol.

S Reiter1, H A Simmonds, N Zöllner, S L Braun, M Knedel.   

Abstract

Genetic heterogeneity has been suggested in xanthinuria from the hitherto unexplained ability of some patients with this hereditary disorder to convert allopurinol to its active metabolite oxipurinol--an activity generally attributed to xanthine oxidase. This study provides evidence that the enzyme aldehyde oxidase is also deficient in xanthinuric patients not converting allopurinol to oxipurinol, whereas a xanthinuric patient with normal formation of oxipurinol had normal aldehyde oxidase activity. It is concluded that the enzyme aldehyde oxidase is the principal enzyme responsible for the formation of oxipurinol in man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323062     DOI: 10.1016/0009-8981(90)90107-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  An unusual patient with kidney stones composed of 1-methyluric acid.

Authors:  Phillip M Davies; Lynette D Fairbanks; Krzysztof Safranow; Michael R Bending; H Anne Simmonds
Journal:  Urol Res       Date:  2006-01-06

Review 2.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

Review 3.  Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout.

Authors:  Lisa K Stamp; Tony R Merriman; Murray L Barclay; Jasvinder A Singh; Rebecca L Roberts; Daniel F B Wright; Nicola Dalbeth
Journal:  Semin Arthritis Rheum       Date:  2014-05-09       Impact factor: 5.532

4.  Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

Authors:  K Ichida; Y Amaya; N Kamatani; T Nishino; T Hosoya; O Sakai
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Modern diagnostic approach to hereditary xanthinuria.

Authors:  Martin Mraz; Olha Hurba; Josef Bartl; Zdenek Dolezel; Anthony Marinaki; Lynette Fairbanks; Blanka Stiburkova
Journal:  Urolithiasis       Date:  2014-11-06       Impact factor: 3.436

6.  Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies.

Authors:  Y Moriwaki; T Yamamoto; K Yamaguchi; S Takahashi; K Higashino
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

Review 7.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 8.  Allopurinol hypersensitivity: investigating the cause and minimizing the risk.

Authors:  Lisa K Stamp; Richard O Day; James Yun
Journal:  Nat Rev Rheumatol       Date:  2015-09-29       Impact factor: 20.543

Review 9.  Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.

Authors:  Richard O Day; Garry G Graham; Mark Hicks; Andrew J McLachlan; Sophie L Stocker; Kenneth M Williams
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

10.  Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning.

Authors:  C David Williams; Mitchell R McGill; Margitta Lebofsky; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-12-15       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.